Oral Docosahexaenoic acid supplementation in Retinopathy of Prematurity in preterm
Phase 2
- Conditions
- Health Condition 1: H578- Other specified disorders of eye and adnexa
- Registration Number
- CTRI/2024/04/066292
- Lead Sponsor
- Cherukula Sahithi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Neonates with gestational age less than 34 weeks
Birth weight less than 2000 grams
Age less than 7 days
Initiated on enteral feeds
Informed and return concern of the parents/guardian
Exclusion Criteria
Neonates with major congenital malformations
Neonates whose mother is on omega 3 supplements
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method